When human fibroblasts from different donors are grown in vitro, only a small fraction of the variation in their finite replicative capacity is explae by the chronological age of the donor. Because we had previously shown that telomeres, the terminal guanine-rich sequences of chromosomes, shorten throughout the life-span of cultured cells, we wished to determine whether variation in initial telomere length would account for the unexplained variation in replicative capacity. Analysis of cells from 31 donors (aged 0-93 yr) indicated relatively weak correlations between proliferative ability and donor age (m = -0.2 doubling per yr; r = -0.42; P = 0.02) and between telomeric DNA and donor age (m = -15 base pairs per yr; r = -0.43; P = 0.02). However, there was a stiking correlation, valid over the entire age range of the donors, between replicative capacity and initial telomere length (m = 10 doublngs per kilobase pair; r = 0.76; P = 0.004), indicating that cell strains with shorter telomeres underwent slglcantiy fewer doublings than those with longer telomeres. These observations suggest that telomere length is a biomarker ofsomatic cell aging in humans and are consistent with a causal role for telomere loss in this process. We also found that fibroblasts from Hutchinson-Gilford progeria donors had short telomeres, consistent with their reduced division potential in vitro. In contrast, telomeres from sperm DNA did not decrease with age ofthe donor, suggesting that a mechanism for maintaining telomere length, such as telomerase expression, may be active in germ-line tissue.
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The cellular senescence model of aging was founded by landmark experiments of Hayflick and Moorhead (1) , who firmly established that normal human fibroblasts have a finite life-span in vitro. Although much evidence supports this model (2) (3) (4) (5) (6) (7) (8) , the mechanism accounting for the finite division capacity of normal somatic cells remains a mystery. Olovnikov (9, 10) suggested that the cause of cellular senescence is the gradual loss of telomeres due to the end-replication problem-i.e., the inability of DNA polymerase to completely replicate the 3' end of linear duplex DNA (11) (for review, see refs. 12 and 13).
Telomeres play a critical role in chromosome structure and function. They prevent aberrant recombination (14) (15) (16) and apparently function in the attachment ofchromosome ends to the nuclear envelope (17) . Telomeres are composed of simple repetitive DNA (for review, see ref. 12) , and in mammals this sequence is (TTAGGG), (18) . These telomeric repeats are elongated by telomerase, a ribonucleoprotein enzyme that extends the 3' end of telomeres (ref. 19 ; for review, see ref. 20) . Thus, in immortal eukaryotic cells, telomerase apparently balances telomere loss with de novo synthesis of telomeric DNA.
Although it is clear that aging in cells, tissues, and organs occurs at many levels and is polygenic (13, 21) , several observations implicate a role for telomere shortening in replicative senescence of cells. (i) Telomeres shorten during aging of cultured fibroblasts (22) and other somatic cells in vivo, including skin epidermal cells (23) and peripheral blood leukocytes and colon mucosa epithelia (24) . In somatic cells, telomere loss may be due to incomplete DNA replication in the absence of telomerase (25, 26) . (ii) There is an increased frequency of chromosomal abnormalities, especially telomeric associations or dicentrics, in senescing fibroblasts (27) (28) (29) . Such chromosomal abnormalities are a hallmark of terminal deletions (14) . (iii) The presence of telomerase in immortal cell lines (26, 30) correlates with stabilized telomere lengths (26) . (iv) The length of sperm telomeres is greater than that of somatic cells (31) (32) (33) . These observations have led to the telomere hypothesis of cellular aging (13) , in which loss of telomeres due to incomplete DNA replication and absence of telomerase provides a mitotic clock that ultimately signals cell cycle exit, limiting the replicative capacity of somatic cells. To further explore this hypothesis, we have examined the relationship between telomere length, in vivo age, and replicative capacity of fibroblasts from normal donors and subjects with the Hutchinson-Gilford syndrome of premature aging (34, 35) . We have also determined the relationship between telomere length in sperm DNA and donor age.
MATERIALS AND METHODS
Cell Culture. Skin samples from surgical specimens or biopsy of various aged donors were cut into pieces 1 mm3 or less in size and used to establish primary cultures (36) . When the first 100-mm dish reached confluence (-3 x 106 cells), the cell population was assigned 16 population doublings. Except as noted, DNA was analyzed from cultures at 19 population doublings. All samples were coded at the time of tissue collection, and the data on mean terminal restriction fragment (TRF) length and culture life-span were collected without knowledge of the donor age. Of the 43 independent strains established and analyzed for TRF measurements (see Fig.   1C ), 31 were selected at random for measurement of total replicative capacity (see Fig. 2 Only those samples having normal sperm count and morphology were used in this study.
Analysis of DNA. DNA was digested with restriction enzymes Rsa I and Hinfl and quantified by fluorometry. One microgram was resolved by electrophoresis in 0.5% agarose gels for 600-700 V-hr. Hybridization of oligonucleotide probes to dried gels was based on a modification of Mather (37) . In brief, gels were dried under vacuum at 600C for [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] min, soaked in 0.5 M NaOH/1.5 M NaCl for 10 min, then soaked in 0.5 M Tris, pH 8/1.5 M NaCI for 10 min, incubated in 5 x standard saline/citrate (SSC) at 370C with 32P-endlabeled (CCCTAA)3 for 8-12 hr, and finally washed three times in 3 x SSC at 480C (10 min each) before exposure to preflashed Kodak XAR film for 1-2 days. Mean TRF length was determined from densitometric analysis of autoradiograms as described (22) . In some experiments, dried gels were directly analyzed by a PhosphorImager (Molecular Dynamics, Sunnyvale, CA) with similar results. In these experiments, the calculation of mean TRF length assumes that the amount of telomeric DNA (TTAGGG repeats) in a given TRF is proportional to the length of that TRF (22) . However, recent data suggest that a large and variable fraction of the TRF is the non-TTAGGG component and that it may be better not to normalize signal strength to TRF length. Both methods, however, yield similar qualitative conclusions with relatively minor changes in calculated mean TRF length (data not shown). 1A) . We have successfully used this method of telomere-length analysis to show that telomeres shorten during replicative aging of human fibroblasts in vitro (22, 25) and possibly in vivo (22) . To firmly establish the effect of chronological aging in vivo on telomere length in fibroblasts, mean TRF length was determined for fibroblast strains at equivalent passage established from 43 donors ranging in age from 0 (fetal or newborn) to 93 yr ( Fig. 1) . A small, but significant decrease in TRF length with age was observed [15 ± 6 base pairs (bp) per yr; P = 0.01]. This loss was accompanied by a decrease in hybridization signal intensity (data not shown), indicating that the shortening of fibroblast TRF length in vivo was from loss of TTAGGG repeats, as was seen during aging of fibroblasts in vitro (22) . Similar results were reported by Lindsey et al. (23) for telomere loss during aging of skin epidermal cells in vivo (20 ± 7 bp per yr).
RESULTS AND DISCUSSION
Mean TRF length of fibroblasts capable of proliferation in vitro decreases =1.5 kbp during the life-span of humans (Fig.  1C) . Because a substantial portion (=4-5 kbp, on average) of the human fibroblast TRF is composed of subtelomeric (non-TTAGGG) repeats (25, 26, 32) , the loss of 1.5 kbp of TTAGGG represents a significant fraction (>30%o) of the initial telomeric DNA at birth. Overall, the mean TRF length of cells from old donors (=7 kbp) is larger than that of senescent cells in vitro (=6 kbp) (22, 25) , consistent with the significant replicative capacity of the cell population established from these donors. Heterogeneity in the length of the non-TTAGGG component in different telomeres (K. R. Prowse, B. S. Abella, A.B.F., C.B.H., and C.W.G., unpublished data), and the presence of some TTAGGG repeats in the proximal region of the TRF can account for hybridization of the telomeric probe to some TRFs shorter than 4-5 kbp (Fig. 1B) .
Telomere Length Predicts Replicative Capacity of Cells. In tion and clonal heterogeneity resulting from the variable in vivo history of cells in a single donor probably contribute to this weak correlation. Similarly, the correlation between TRF length and donor age is also weak (Figs. 1C and 2B ; r = -0.38 and -0.43, respectively). If telomere length were causally linked to cellular life-span, then the initial telomere length of the culture should correlate well with the life-span of that culture, regardless of donor age. Of the 43 strains analyzed for initial TRF length (Fig. 1) , 31 strains were selected at random (see Materials and Methods) for determination of in vitro life-span ( Fig. 2A) . When replicative capacity was plotted as a function ofthe initial TRF length for these strains, a much more significant correlation was found ( Fig. 2C ; r = 0.76; P < 0.004) than that between replicative life-span and donor age ( Fig. 2A ; r = -0.42; P < 0.02). To show that initial TRF length explains a significant portion of the variation in replicative capacity seen throughout the age range of donors, different symbols were used to record the data in Fig. 2 Fig. 2A ). In the same donors, mean TRF length decreased -15 bp per yr (Figs. 1 and 2B ). Ifwe assume that the loss of culture life-span with donor age reflects the average cell doubling rate in vivo (i.e., that the total number of doublings in vivo and in vitro is constant for a given population of cells), then we obtain =75 bp per population doubling for the in vivo rate of telomere shortening in human fibroblasts. This rate is similar to that observed for telomere shortening in vitro (48 + 21 bp per population doubling) (22, 25) but significantly greater than that for terminal DNA loss in yeast defective for telomere maintenance (40) or in Drosophila mutants with broken chromosomes (41) (42) (43) . Analysis of DNA loss in these organisms suggested that as few as 2-4 bp were lost from the end of the chromosome per cell doubling. However, many factors could account for the difference between rates of telomere loss in normal human somatic cells and these eukaryotes, such as differences in the extent of incomplete replication, telomerase activity, or exonuclease activity.
Maintenance of Telomere Length in Sperm. Because the germ-line lineage is immortal, a mechanism to maintain telomere length must be active at some stage of germ-line development. To test this, we measured mean TRF length for sperm from 63 donors ranging in age from 19 to 68 yr and found that it increased slightly with age (Fig. 4) . Analysis of the integrated signal from the telomeric probe hybridized to the TRFs showed greater experimental variation but also indicated that the TTAGGG abundance did not decrease with age (data not shown). These observations are consistent with the idea that telomerase may be active in germ-line tissue, 12.
9-8o- lished data). The loss oftelomeric DNA during aging ofhuman fibroblasts (22) , keratinocytes (23) , leukocytes (24) , epithelial cells (24, 26) , and endothelial cells (E. Chang and C.B.H., unpublished data) is consistent with a general lack of telomerase in untransformed somatic cells. These observations, together with maintenance oftelomere length in germ-line cells (Fig. 4) , suggest a role for telomeres and telomerase in cell aging and immortalization (Fig. 5) . We suggest that telomerase is (i) active in germ-line cells, (ii) repressed early in embryonic development in most somatic cells, and (iii) reactivated in somatic cells immortalized during tumorigenesis.
Counter et al. (26) showed that simian virus 40 large T antigen and adenovirus 5 oncogenes can extend the life-span of human embryonic kidney cells without directly activating telomerase. Hence, during the extended life-span phase of these cultures, telomeres continued to shorten until a "crisis" point, when most cells die. Telomerase was detected only in the relatively rare immortal clones that survived crisis, and in these cells telomere length was stable. The two breakpoints in Fig. 5 representing replicative senescence and crisis correspond to mortality phase 1 (Ml) and mortality phase 2 (M2), as defined by Wright et al. (44) . The mean telomere length at these points are designated Ti and T2. We assume that Ml is a checkpoint in cell growth when one or more telomeres reach a critical minimum length. Viral oncogenes and other agents may be able to bypass this checkpoint without activating telomerase, thus compromising genetic stability while telomeres continue to shorten. At M2, telomere length may be severely shortened on many chromosomes, leading to a dramatic increase in chromosomal instability and cell death (26) (46, 47) is more difficult, but not impossible, to explain with the telomere hypothesis. However, cells senesce and organisms age for many different reasons, and it is certain that telomeres and telomerase are not involved in all aspects of this multifactorial process (13) .
In summary, our observations suggest that the gradual shortening of telomeres in human somatic cells that lack telomerase provides a good marker of replicative capacity in vitro and in vivo. Moreover, the tight correlation of telomere length to replicative capacity suggests that telomere loss may initiate cell cycle exit once a critical or "threshold" number of telomeric TTAGGG repeats is reached. It should be possible to test whether telomere loss and telomerase expression are coincidental or causal in cell senescence and immortalization once methods become available to alter these activities in multicellular eukaryotes.
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